Emerging immunotherapies in Cancer2020-09-21T14:36:54+00:00
Emerging immunotherapies in Cancer
17-Sep-2020
Virtual

After the great success of its first edition, we are glad to announce the second edition of the “Emerging Immunotherapies in Cancer” workshop, an excellent learning and networking platform for healthcare professionals and translational researchers involved in cancer immunotherapy. For this second edition, we have prepared an online edition, so you can virtually join us worldwide.

During the last decade, immunotherapy has meant a breakthrough as a therapy in cancer. In this regard, there are more and more therapeutic tools that help boost the immune system with the aim of attacking cancer cells. In this workshop, some of the key opinion leaders, both national and international, will analyze the next generation of vaccines, drugs and potential immunotherapeutic procedures to treat cancer.

Coordinadors

Antoni Ribas
Jonsson Comprehensive Cancer Center David Geffen School of Medicine. University of California Los Angeles. USA.
Leticia de Mattos Arruda
Principal Investigator at IrsiCaixa Research Institute. Barcelona, Spain.
Maria González Cao
Oncology department, Instituto oncológico Dr. Rosell Hospital Dexeus, Barcelona
Rafael Rosell
Medical director and president of the Instituto oncológico Dr. Rosell (Grupo QuirónSalud) Specialized in thoracic tumors
VIEW PROGRAM
REGISTER HERE

The Emerging Immunotherapies in Cancer – II edition, Barcelona, Spain, 17/09/2020 has been accredited by the European Accreditation Council for Continuing Medical Education (EACCME®) with 4 European CME credits (ECMEC®s). Each medical specialist should claim only those hours of credit that he/she actually spent in the educational activity.

For more information please contact info@fls-science.com

Sponsors
Details
Emerging immunotherapies in Cancer
17-Sep-2020
Virtual
English
Organisation
Phone
+34 93 497 83 46
Mail
info@fls-science.com